Pages that link to "Q36517507"

The following pages link to Whole genome methylation profiles as independent markers of survival in stage IIIC melanoma patients (Q36517507):

Displaying 21 items.

• Epigenetic mechanisms involved in melanoma pathogenesis and chemoresistance (Q26778761) (← links)
• Emerging technologies for studying DNA methylation for the molecular diagnosis of cancer (Q28087759) (← links)
• DNA methylation characteristics of primary melanomas with distinct biological behaviour. (Q33617915) (← links)
• Prognostic significance of LINE-1 hypomethylation in oropharyngeal squamous cell carcinoma. (Q33742722) (← links)
• DNA methylation profiles in primary cutaneous melanomas are associated with clinically significant pathologic features. (Q34416046) (← links)
• Validation of DNA methylation to predict outcome in acute myeloid leukemia by use of xMELP (Q35259528) (← links)
• DNA methylation subgroups in melanoma are associated with proliferative and immunological processes (Q35834765) (← links)
• Common BRAF(V600E)-directed pathway mediates widespread epigenetic silencing in colorectal cancer and melanoma (Q36563162) (← links)
• Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis. (Q37380194) (← links)
• Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities. (Q37737945) (← links)
• Epigenetics of melanoma: implications for immune-based therapies. (Q38148588) (← links)
• Epigenetics of human melanoma: promises and challenges. (Q38217482) (← links)
• Genome-Wide DNA Methylation Analysis in Melanoma Reveals the Importance of CpG Methylation in MITF Regulation (Q38906998) (← links)
• Implementing liquid biopsies into clinical decision making for cancer immunotherapy (Q39304648) (← links)
• HumanMethylation450K Array-Identified Biomarkers Predict Tumour Recurrence/Progression at Initial Diagnosis of High-risk Non-muscle Invasive Bladder Cancer. (Q49988036) (← links)
• Prognostic Significance of Promoter Hypermethylation and Diminished Gene Expression of SYNPO2 in Melanoma (Q50589475) (← links)
• Demethylation by low-dose 5-aza-2'-deoxycytidine impairs 3D melanoma invasion partially through miR-199a-3p expression revealing the role of this miR in melanoma (Q61447666) (← links)
• A four-DNA methylation biomarker is a superior predictor of survival of patients with cutaneous melanoma. (Q64915632) (← links)
• Better prognostic determination and feature characterization of cutaneous melanoma through integrative genomic analysis (Q92017516) (← links)
• Aberrant DNA Methylation Predicts Melanoma-Specific Survival in Patients with Acral Melanoma (Q92328856) (← links)
• Effect of Sulforaphane and 5-Aza-2'-Deoxycytidine on Melanoma Cell Growth (Q93108792) (← links)